Cherubisam

Reading File
Finding Sources
Searching the Web

cherubism clinical features pathology treatment 2024

Reading File
Reading File
Reading File
Here is a comprehensive overview of Cherubism:

Cherubism

Definition & Genetics

Cherubism is a rare, autosomal dominant fibro-osseous disorder of the jaws caused by gain-of-function mutations in the SH3BP2 gene (chromosome 4p16.3). SH3BP2 is a cytoplasmic adaptor protein that interacts with TNFAIP3/A20 and protein tyrosine kinases (ABL1, SYK) that regulate transcriptional activity in immune cells. Approximately 50% of cases are de novo mutations (no family history). Penetrance is gender-dependent: ~100% in males, 50-70% in females. Around 10-20% of cases have no identified SH3BP2 mutation, suggesting additional genetic heterogeneity.

Epidemiology & Age of Onset

  • Rare disorder; precise incidence unknown
  • Onset typically 2-5 years of age
  • Affects children; lesions often spontaneously regress after puberty

Clinical Features

FeatureDetails
Facial appearanceBilateral, symmetric fullness/swelling of the lower face (jaw) - "chubby cheeks" resembling cherubs in Renaissance paintings
MandibleMost prominently affected - posterior rami/angles
MaxillaAlso affected in more severe cases
EyesUpward deviation of the eyes (exposure of inferior sclera) due to floor of orbit involvement; can cause visual problems in severe disease
TeethDelayed eruption, displacement, mobility, root resorption, failure of permanent teeth to develop
Lymph nodesSubmandibular and cervical lymphadenopathy
Speech/SwallowingImpaired in severe cases
RespiratoryCan cause airway compromise in aggressive disease
Severity ranges widely - from subclinical lesions to severe maxillomandibular overgrowth. - K.J. Lee's Essential Otolaryngology; Scott-Brown's Otorhinolaryngology, Vol. 1

Pathology

  • Lesions consist of giant cell reparative granulomas replacing normal bone with fibrous tissue
  • Histology: cellular fibroblastic stroma containing aggregates of multinucleated giant cells (smaller and fewer nuclei than true giant cell tumour)
  • Histologically indistinguishable from giant cell granuloma and the solid variant of aneurysmal bone cysts
  • Mitoses may be present (benign despite this)
  • Pathological mechanism: SH3BP2 mutation leads to abnormal osteoclast activity and exaggerated inflammatory signaling via NF-kB and RANKL pathways

Radiology

  • Plain X-ray/CT: Bilateral, symmetric multilocular radiolucent/lytic ("soap bubble") lesions in the mandible +/- maxilla
  • Expanded bone with coarse trabecular pattern and cortical thinning
  • CT shows expansile lytic lesions with well-demarcated edges
  • Submandibular lymphadenopathy may be visible
  • Grainger & Allison's Diagnostic Radiology; Radiopaedia - Cherubism

Diagnosis

Diagnosis is based on:
  1. Characteristic clinical presentation (bilateral jaw swelling in a child)
  2. Imaging (bilateral multilocular radiolucency)
  3. Histopathology (giant cell lesion)
  4. Molecular genetic testing (SH3BP2 pathogenic variant)
Differential diagnosis includes:
  • Brown tumour of hyperparathyroidism (check serum calcium, phosphate, alkaline phosphatase)
  • Fibrous dysplasia
  • Central giant cell granuloma
  • Aneurysmal bone cyst

Classification (by severity)

  1. Inactive lesions - typically found in adolescence; non-progressive
  2. Non-aggressive lesions - seen in younger children; very slow growth
  3. Aggressive lesions - childhood onset; rapid expansion; tooth mobility, root resorption, cortical bone weakening

Treatment

ApproachDetails
Watchful waitingFirst-line for most; majority regress spontaneously after puberty (increased sex steroids normalize osteoclast activity)
SurgeryReserved for significant cosmetic deformity, functional compromise (airway, vision, swallowing), or aggressive lesions. Includes curettage, osteoplasty, bone recontouring
CurettageAssociated with ~15% recurrence; excision preferred where possible
Dental managementExtraction of teeth from areas of fibrous change
DenosumabEmerging therapy - a 2024 report documented successful treatment with denosumab 60 mg every 6 months in adult cherubism, targeting osteoclast activity via RANKL inhibition
TimingEarly surgical intervention before puberty may be needed in severe cases; conservative post-pubertal recontouring is preferred if possible

Prognosis

Most cases self-limit and regress during the second and third decades of life. Severe cases can cause permanent jaw deformity, dental loss, or orbital/visual complications. Early recognition and appropriate monitoring are key to preventing long-term morbidity.
This is a shared conversation. Sign in to Orris to start your own chat.